Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Private Equity | Alive

About Fenoglide

Provider of the cholesterol lowering drug for the treatment of hyperlipidemia and hypertriglyceridemia. The company's product utilizes a clinically validated reformulation technology, designed to provide improved absorption and bioavailability of the drug. The product is available in 40 mg and 120 mg tablets.

Fenoglide Headquarter Location

5 Concourse Parkway Suite 1800

Atlanta, Georgia, 30328,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.